Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.72 USD | -1.72% | -11.10% | +7.76% |
May. 16 | Craig-Hallum Adjusts Price Target on Celcuity to $27 From $25, Assumes Buy Rating | MT |
May. 16 | Celcuity Q1 Net Loss Widens; Shares Rise After Hours | MT |
Chart calendar Celcuity Inc.
Upcoming events on Celcuity Inc.
Past events on Celcuity Inc.
2024-05-15 04:30 pm | Q1 2024 Earnings Call |
2024-05-15 04:01 pm | Q1 2024 Earnings Release |
2024-05-09 10:00 am | Annual General Meeting |
2024-04-17 10:00 am | Stifel Virtual Targeted Oncology Days Conference - Fireside Chat |
2024-04-11 02:15 pm | Needham Healthcare Conference - Fireside Chat |
2024-03-27 04:30 pm | Q4 2023 Earnings Call |
2024-03-27 04:01 pm | Q4 2023 Earnings Release |
2024-03-13 08:40 am | Leerink Partners Global Biopharma Conference |
2024-03-06 02:10 pm | TD Cowen Health Care Conference - Fireside Chat |
2023-12-06 01:00 pm | San Antonio Breast Cancer Symposium - PO1-24-04 |
2023-11-29 12:30 pm | Evercore ISI HealthCONx Conference |
2023-11-16 04:00 am | Jefferies London Healthcare Conference |
2023-11-14 04:10 pm | Stifel Healthcare Conference |
2023-11-13 08:00 am | Q3 2023 Earnings Call |
2023-11-13 07:05 am | Q3 2023 Earnings Release |
2023-09-21 10:00 am | Investor Meeting |
2023-08-10 04:30 pm | Q2 2023 Earnings Call |
2023-08-10 04:00 pm | Q2 2023 Earnings Release |
2023-08-06 | BTIG Virtual Biotechnology Conference |
2023-06-09 12:15 pm | Jefferies Global Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 -66,5 - | -85,4 |
EBIT Million USD | Released Forecast Spread | -6,76 -7,60 10.98% | -9,56 -9,50 -0.56% | -28,4 -28,0 -1.15% | -39,4 -38,9 -1.34% | -66,2 -65,1 -1.74% | -97,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,36 -7,52 2.14% | -9,47 -9,46 -0.16% | -29,6 -29,3 -1.09% | -40,4 -40,0 -0.98% | -63,8 -62,8 -1.63% | -91,9 |
Net income Million USD | Released Forecast Spread | -7,36 -7,52 2.14% | -9,47 -9,46 -0.16% | -29,6 -29,1 -1.78% | -40,4 -40,0 -0.98% | -63,8 -62,8 -1.63% | -94,7 |
EPS USD | Released Forecast Spread | -0,72 -0,74 2.7% | -0,92 -0,93 0.54% | -2,21 -2,12 -4.12% | -2,64 -2,01 -31.51% | -2,69 -2,78 3.18% | -2,77 |
Announcement Date | 13/03/20 | 16/02/21 | 23/03/22 | 23/03/23 | 27/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 1,26 | 2,94 | 0,00 | 0,00 |
EBITDA Million USD | Released Forecast Spread | -12,5 -13,7 8.73% | -15,0 -14,6 -2.86% | -18,9 -17,1 -10.32% | -20,0 | -21,0 | -21,0 | -21,0 | -21,3 | -21,4 | |||||
EBIT Million USD | Released Forecast Spread | -7,51 -6,86 -9.38% | -9,60 -7,94 -20.84% | -10,6 -9,93 -7.2% | -11,6 -11,1 -4.8% | -12,5 -13,2 5.13% | -15,1 -13,7 -9.52% | -18,9 -16,1 -17.14% | -19,7 -19,9 1.1% | -22,5 -20,9 -7.51% | -23,5 | -24,9 | -27,0 | -33,2 | -38,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,93 -6,67 -18.99% | -9,96 -8,10 -22.99% | -10,9 -10,1 -8.22% | -11,6 -11,2 -3.52% | -11,9 -13,5 11.5% | -14,6 -14,2 -2.65% | -18,4 -16,4 -12.39% | -18,8 -19,1 1.09% | -21,6 -20,6 -5.09% | -22,9 | -24,7 | -26,5 | -23,6 | -23,7 |
Net income Million USD | Released Forecast Spread | -7,93 -7,05 -12.47% | -9,96 -8,23 -21.09% | -10,9 -10,2 -6.67% | -11,6 -11,2 -3.52% | -11,9 -13,5 11.5% | -14,6 -14,2 -2.65% | -18,4 -16,4 -12.39% | -18,8 -19,0 0.93% | -21,6 -20,1 -7.61% | -22,7 | -24,5 | -27,1 | -33,4 | -38,8 |
EPS USD | Released Forecast Spread | -0,53 -0,47 -12.17% | -0,67 -0,50 -33.33% | -0,75 -0,58 -28.76% | -0,69 -0,44 -57.71% | -0,55 -0,52 -6.28% | -0,66 -0,60 -10.46% | -0,83 -0,68 -21.61% | -0,65 -0,73 10.75% | -0,64 -0,70 8.31% | -0,69 | -0,70 | -0,66 | -0,84 | -0,92 |
Announcement Date | 16/05/22 | 11/08/22 | 10/11/22 | 23/03/23 | 15/05/23 | 10/08/23 | 13/11/23 | 27/03/24 | 15/05/24 | - | - | - | - | - |
Past sector events for Celcuity Inc.
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CELC Stock
- Calendar Celcuity Inc.